Pegvisomant
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Pegvisomant, covering 2008-03-04 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance [Phase 2]